ElitePhysiqMD review

ElitePhysiqMD separates a medication purchase from a membership that discounts refills and waives specified visit and shipping fees. Current pages describe a monthly membership, an activation payment and a lower first membership period, followed by the standard recurring membership charge. One-time orders instead add an examination fee and shipping to the undiscounted medication price. The medication selector is not an all-in total unless those components and the selected supply are included. Ask for an itemized quote showing the first payment, recurring medication amount, membership renewal and one-time fees before comparing programs. The semaglutide cost guide explains how introductory and standing costs differ.

Supply duration and charge interval need particular care here. The semaglutide and tirzepatide pages describe a four-week option as 28 days of medication. Their three-month option supplies 84 days in one shipment but explicitly bills every three months on subscription. That is not the same as charging every 28 days. The shorter option’s refill language and monthly price labels should be confirmed in the selected agreement rather than converted into an assumed annual renewal count. Current tirzepatide figures also differ from older pricing, and the cost varies with the selected supply and dose. A subscription discount does not establish that future prescribed strengths cost the same. Confirm any price adjustment when the physician selects a different prescription from the shopping selection.

The company’s standards page describes a live physician video visit before prescribing, rather than an entirely automated questionnaire. Its product pages identify Qualiphy on the telehealth-visit line. ElitePhysiqMD says it facilitates the platform and pharmacy coordination without employing the prescribers or making their medical decisions. Its broad network coverage statement does not independently verify the treating practitioner’s authority for your location or establish that every therapy is available there. Ask for the assigned practice, clinician and dispenser. Public statements about 503A and 503B pharmacy categories are not a specific license check or FDA approval of a preparation. Member lab-upload features do not establish that all medically needed testing is included or that no testing will be required.

Refund wording must be read at the right level. The semaglutide page says medication is not charged if the clinician finds treatment unsuitable, and shipment follows approval. General platform terms describe transactions as nonrefundable, with no credit for partially used membership time except where law requires otherwise. Those statements do not establish a refund of every activation, visit or membership charge after clinical denial. Ask which fees are authorized before the visit, which are captured only after approval and what happens if a different dose changes the price. Canceling membership preserves access through the paid period; it should not be assumed to cancel a medication order already transmitted to a pharmacy.

The menu includes injectable and sublingual products, longer packs, microdose options and a broader peptide catalog. These are distinct preparations, rather than interchangeable versions supported by the same clinical trials. Brand semaglutide study results do not establish equivalence for an individual compounded injection or under-the-tongue product. Retatrutide remains investigational, and listing it for sale does not establish a lawful ordinary prescribing or compounding pathway. Other ingredients need their own regulatory analysis rather than a blanket conclusion that every compounded peptide is prohibited. The retatrutide article explains that distinction. Use the semaglutide lineup after the formulation, care arrangement and complete binding charges are clear.